Literature DB >> 30310483

Diabetes Mellitus and Heart Failure.

Dimitris Tousoulis1, Evangelos Oikonomou1, Gerasimos Siasos1, Christodoulos Stefanadis1.   

Abstract

Diabetes mellitus and heart failure are two multifaceted entities characterised by high morbidity and mortality. Early epidemiological and prospective studies have observed the frequent co-existence of both conditions. Importantly, diabetes mellitus can precipitate or worsen heart failure due to the accumulation of advanced glycation end products, oxidative stress, inflammatory status impairment, decay of intracellular calcium, changes in microRNAs expression, not to mention atherosclerosis progression and coronary artery disease. Heart failure also impairs glucose metabolism through less well-known mechanisms. Attention must especially be given in the treatment as there are frequently adverse interactions between the two diseases and novel agents against diabetic cardiomyopathy are under investigation. As several missing links still exist in the connection between heart failure and diabetes mellitus we will review, in this article, the most recent data underlying the interaction of them and provide an overview of the most important clinical perspectives.

Entities:  

Keywords:  Diabetes mellitus; heart failure; inflammation; oxidative stress; pathophysiology; treatment

Year:  2014        PMID: 30310483      PMCID: PMC6159396          DOI: 10.15420/ecr.2014.9.1.37

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  85 in total

1.  Drug-induced hyperglycemia.

Authors:  B Luna; M N Feinglos
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

Authors:  George G Sokos; Lazaros A Nikolaidis; Sunil Mankad; Dariush Elahi; Richard P Shannon
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

4.  Predictors of readmission among elderly survivors of admission with heart failure.

Authors:  H M Krumholz; Y T Chen; Y Wang; V Vaccarino; M J Radford; R I Horwitz
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

5.  Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

Authors:  Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

6.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

7.  Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.

Authors:  Mads Halbirk; Helene Nørrelund; Niels Møller; Jens Juul Holst; Ole Schmitz; Roni Nielsen; Jens Erik Nielsen-Kudsk; Søren Steen Nielsen; Torsten Toftegaard Nielsen; Hans Eiskjaer; Hans Erik Bøtker; Henrik Wiggers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

Review 8.  Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Authors:  Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-12       Impact factor: 15.534

9.  Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy.

Authors:  Jiehua Li; Shiyue Su; Xiaona Zong
Journal:  Exp Ther Med       Date:  2014-02-12       Impact factor: 2.447

10.  Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.

Authors:  Kai-Hang Yiu; Kui-Kai Lau; Chun-Ting Zhao; Yap-Hang Chan; Yan Chen; Zhe Zhen; Arthur Wong; Chu-Pak Lau; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2014-03-25       Impact factor: 9.951

View more
  9 in total

1.  Cardiometabolic medicine: time to recognize a new clinical specialty?

Authors:  Andrew J Krentz; Stephan Jacob
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

Review 2.  Use of Digital Health Technology in Heart Failure and Diabetes: a Scoping Review.

Authors:  Dania Kallas; Navroop Sandhu; Christina Gandilo; Mary Schleicher; Laura Banks; Mariam Jabara; Luiz Alberto Cerqueira Batista Filho; Tracey J F Colella; Kim Connelly; Varinder Kaur Randhawa
Journal:  J Cardiovasc Transl Res       Date:  2022-05-31       Impact factor: 3.216

3.  Using Iterative Pairwise External Validation to Contextualize Prediction Model Performance: A Use Case Predicting 1-Year Heart Failure Risk in Patients with Diabetes Across Five Data Sources.

Authors:  Ross D Williams; Jenna M Reps; Jan A Kors; Patrick B Ryan; Ewout Steyerberg; Katia M Verhamme; Peter R Rijnbeek
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

4.  Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.

Authors:  Palvinder Kaur; Nakul Saxena; Alex Xiaobin You; Raymond C C Wong; Choon Pin Lim; Seet Yoong Loh; Pradeep Paul George
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

5.  Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

Authors:  Konstantinos A Gatzoulis; Dimitrios Tsiachris; Petros Arsenos; Christos-Konstantinos Antoniou; Polychronis Dilaveris; Skevos Sideris; Emmanuel Kanoupakis; Emmanouil Simantirakis; Panagiotis Korantzopoulos; Ioannis Goudevenos; Panagiota Flevari; Efstathios Iliodromitis; Antonios Sideris; Vassilios Vassilikos; Nikolaos Fragakis; Konstantinos Trachanas; Michail Vernardos; Ioannis Konstantinou; Konstantinos Tsimos; Iosif Xenogiannis; Konstantinos Vlachos; Athanasios Saplaouras; Konstantinos Triantafyllou; Ioannis Kallikazaros; Dimitrios Tousoulis
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

6.  Association of antecedent cardiovascular risk factor levels and trajectories with cardiovascular magnetic resonance-derived cardiac function and structure.

Authors:  Roberto Lorbeer; Susanne Rospleszcz; Christopher L Schlett; Sophia D Rado; Barbara Thorand; Christa Meisinger; Wolfgang Rathmann; Margit Heier; Ramachandran S Vasan; Fabian Bamberg; Annette Peters; Wolfgang Lieb
Journal:  J Cardiovasc Magn Reson       Date:  2021-01-04       Impact factor: 5.364

7.  Predictive Factors on the Incidence of Heart Failure in Patients with Ischemic Heart Disease: Using a 10-Year Population-Based Korea National Health Insurance Cohort Data.

Authors:  Seon Young Hwang; Kyung Ae Kim; Oh Jong Choi
Journal:  Int J Environ Res Public Health       Date:  2020-11-22       Impact factor: 3.390

Review 8.  Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention.

Authors:  Mohapradeep Mohan; Adel Dihoum; Ify R Mordi; Anna-Maria Choy; Graham Rena; Chim C Lang
Journal:  Front Cardiovasc Med       Date:  2021-09-29

9.  Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis.

Authors:  Gloria M Gager; Georg Gelbenegger; Bernd Jilma; Dirk von Lewinski; Harald Sourij; Ceren Eyileten; Krzysztof Filipiak; Marek Postula; Jolanta M Siller-Matula
Journal:  Front Cardiovasc Med       Date:  2021-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.